Stocktoria
Jiangsu Hengrui Pharmaceuticals Co.,Ltd 600276.SS
CN · Shanghai Stock Exchange · XSHG · stock · Healthcare · website
Jiangsu Hengrui Pharmaceuticals Co.,Ltd statistics & valuation
Market cap$352.8B
P / E45.7×
P / S11.2×
P / B5.8×
P / FCF42.6×
Dividend yield0.36%
Net margin24.4%
Return on equity12.6%
FCF margin26.2%
Multiples are price-derived and refreshed daily; everything else is from filings.
P / E vs its own history
Jiangsu Hengrui Pharmaceuticals Co.,Ltd trades at about 44.1× earnings — below its 10-year norm (10-year range 44.7×–69.2×, median 55.1×).
44.1×
69.2×
Shaded band = 10-year range (44.7×–69.2×); dot = today's 44.1×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 86.2% | 86.2% | 84.6% | 83.6% |
| Operating margin | 27.2% | 24.3% | 20.3% | 15.7% |
| Net margin | 24.4% | 22.6% | 18.9% | 18.4% |
| FCF margin | 26.2% | 19.5% | 27.0% | -3.4% |
| Return on assets | 11.0% | 12.6% | 9.8% | 9.2% |
| Return on equity | 12.6% | 13.9% | 10.6% | 10.3% |
| Current ratio | 8.08 | 9.72 | 12.25 | 8.50 |
Source: company filings via Yahoo Finance · CN · as of 2025-12-31. Figures in CNY; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.